![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.135 | -2.91% | 4.51 | 4.41 | 4.99 | 4.53 | 4.51 | 4.53 | 189,892 | 11:53:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/7/2020 21:10 | Why don't you join? I can award you some coins if you want and can then admit you to the Guild? | ![]() nobbygnome | |
20/7/2020 21:09 | Nobby, please post here more and keep us updated as I don't have access to your other board. Many thanks! | ![]() 1findlaydarr | |
20/7/2020 21:08 | Very sincere Thanks for all your guidance and expert information Nobbygnome. I'm sure most of us would not have stuck with SNG if it were not for your insight. | ![]() ambyth | |
20/7/2020 21:05 | I sold 5% today but will hold the rest. This is the beginning of the end not the end. A takeover or licensing deal is highly likely now in the short term IMHO..... | ![]() nobbygnome | |
20/7/2020 20:58 | And Thankyou .It's refreshing | ![]() amaretto1 | |
20/7/2020 20:57 | i actually stopped in because of u Nobby ! Cheers for your honesty | ![]() amaretto1 | |
20/7/2020 20:43 | Hello all. Rather a good day wasn't it..... | ![]() nobbygnome | |
20/7/2020 20:38 | “This assessment of SNG001 in COVID-19 patients could signal a major breakthrough in the treatment of hospitalised COVID-19 patients, said Richard Marsden, CEO of Synairgen, a respiratory drug discovery and development company which originated from research at the University of Southampton. We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from requiring oxygen’ to requiring ventilation’. It also showed that patients who received SNG001 were at least twice as likely to recover to the point where their everyday activities were not compromised through having been infected by SARS-CoV-2 (COVID-19), he said. In addition, SNG001 significantly reduced breathlessness, one of the main symptoms of severe COVID-19, the company said, which is now focused on working with the regulators and other key groups to progress the potential COVID-19 treatment as rapidly as possible. The trials showed that the average time coronavirus patients spent in hospital was reduced by a third, for those | ![]() hazl | |
20/7/2020 20:21 | C4XD .... trust me !! | ![]() amaretto1 | |
20/7/2020 20:15 | Maybe EVGEN or STX? Here's hoping anyway! | ![]() lovewinshatelosses | |
20/7/2020 20:09 | Hazl...anything over 100% iirc does not register on the top risers board. | ![]() dovey21 | |
20/7/2020 20:08 | Hmm unlikely... but I wish you the best of luck ;-) | ![]() rmc100 | |
20/7/2020 20:05 | What next is Trump buys up all the production!Minimum 1 million courses at 1 thousand a time = 1 billion pounds in sales and this share will go crazy!!!!! | ![]() dave444 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions